International Journal of Gynecological Cancer

Gynecological cancers in developing countries: the challenge of chemotherapy in low-resources setting
pp. 1491-1497(7)
Authors: BASILE,; ANGIOLI,; MANCI,; PALAIA,; PLOTTI,; BENEDETTI PANICI,

Who should be vaccinated against human papillomavirus?
pp. 1498-1499(2)
Authors: TJALMA,; VAN DAMME,

Immunobiology of gestational trophoblastic diseases
pp. 1500-1515(16)
Authors: WANG,; FU,; FREEDMAN,; LIU,; KAVANAGH,

Gynecological tumors revealing hereditary nonpolyposis colorectal cancer: analysis of a large Lebanese pedigree
pp. 1516-1521(6)
Authors: AKOUM,; GHAOUI,; BRIHI,; GHABASH,; ABOU ATME, J.

Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study
pp. 1522-1528(7)
Authors: MARTH,; WINDBICHLER,; HAUSMANINGER,; PETRU,; ESTERMANN,; PELZER,; MUELLER-HOLZNER,

High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels
pp. 1529-1535(7)
Authors: LANCASTER,; SAYER,; BLANCHETTE,; CALINGAERT,; KONIDARI,; GRAY,; SCHILDKRAUT,; SCHOMBERG,; MARKS,; BERCHUCK,

Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property
pp. 1536-1544(9)
Authors: JANDU,; RICHARDSON,; SINGH,; HIRTE,; HATTON,

Activation of mammalian target of rapamycin in postmenopausal ovarian endometriosis
pp. 1545-1551(7)
Authors: YAGYU,; TSUJI,; HARUTA,; KITANAKA,; YAMADA,; KAWAGUCHI,; KANAYAMA,; TANASE,; KURITA,; KOBAYASHI,

Arsenic trioxide exposure to ovarian carcinoma cells leads to decreased level of topoisomerase II and cytotoxicity
pp. 1552-1556(5)
Authors: ASKAR,; CIRPAN,; TOPRAK,; KARABULUT,; SELVI,; TEREK,; USLU,; SANLI,; GOKER,

Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma
pp. 1557-1564(8)
Authors: STAFLIN,; JÄRNUM,; HUA,; HONETH,; KANNISTO,; LINDVALL,

Women in a region with high incidence of cervical cancer warrant immediate colposcopy for low-grade squamous intraepithelial lesion on cervical cytology
pp. 1565-1568(4)
Authors: PHONGNARISORN,; SRISOMBOON,; SIRIAUNGKUL,; KHUNAMORNPONG,; SUPRASERT,; CHAROENKWAN,; CHEEWAKRIANGKRAI,; SIRIAREE,; SAPHAN,

What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study
pp. 1569-1573(5)
Authors: LEE,; PARK,; CHO,; HA,

Loop conization for the treatment of microinvasive carcinoma of the cervix
pp. 1574-1578(5)
Authors: TSENG,; CHANG,; HOU,; WANG,; CHEN,; SOONG,; PAO,

A comparative study of two devices used for cervical cell sampling raises some doubts about liquid-based cytology
pp. 1579-1586(8)
Authors: KOTHARI,; KARIM,; GORDON,; RASLAN,; ABDALLA,; GEORGE,

Urine cytology as a screening test for bladder infiltration in cervical cancer
pp. 1587-1590(4)
Authors: SNYMAN,; ZONDAGH,; DREYER,; LINDEQUE,; LOUW,

Human papillomavirus genotypes associated with cervical neoplasia in India
pp. 1591-1595(5)
Authors: PEEDICAYIL,; ABRAHAM,; SATHISH,; JOHN,; SHAH,; SRIDHARAN,; GRAVITT,

Candida and squamous (pre)neoplasia of immigrants and Dutch women as established in population-based cervical screening
pp. 1596-1600(5)
Authors: ENGBERTS,; VERMEULEN,; VERBRUGGEN,; vanHAAFTEN,; BOON,; HEINTZ,

Detection of human papillomavirus in organs of upper genital tract in women with cervical cancer
pp. 1601-1607(7)
Authors: GIORDANO,; D'ADDA,; GNETTI,; FROIO,; MERISIO,; MELPIGNANO,

Risk factors for the progression or persistence of untreated mild dysplasia of the uterine cervix
pp. 1608-1613(6)
Authors: SONG,; LEE,; OH,; HUR,; PARK,; SAW,

A phase I study of concurrent cisplatin chemotherapy in patients with carcinoma of the cervix receiving pelvic radiotherapy
pp. 1614-1619(6)
Authors: NYONGESA,; RUFF,; DONDE,; KOTZEN,

Enhanced radiation-mediated cell killing of human cervical cancer cells by small interference RNA silencing of ataxia telangiectasia-mutated protein
pp. 1620-1630(11)
Authors: LI,; JIAN,; XIAOPING,; YINGFENG,; TAO,; XIAOYAN,

Upregulation of CD44 expression by interleukins 1, 4, and 13, transforming growth factor-β1, estrogen, and progestogen in human cervical adenocarcinoma cell lines
pp. 1631-1642(12)
Authors: IBRAHIM,; STEWART,; CORKE,; BLACKETT,; TIDY,; WELLS,

Reverse transcription-polymerase chain reaction and western blotting analysis for detection of p63 isoforms in uterine cervical cancers
pp. 1643-1647(5)
Authors: LIN,; NAN,; ZHANG,; ZHAO,; KIM,

Stage III and IV endometrial cancer: a 20-year review of patients
pp. 1648-1655(8)
Authors: vanWIJK,; HUIKESHOVEN,; ABDULKADIR,; EWING,; BURGER,

Function of estrogen receptor isoforms α and β in endometrial carcinoma cells
pp. 1656-1660(5)
Authors: ZHANG,; LIAO,; CHEN,; YU,; ZHAO,

Mitochondrial polymorphisms as risk factors for endometrial cancer in southwest China
pp. 1661-1667(7)
Authors: XU,; HU,; CHEN,; TANG,; HAN,; YU,; XIAO,

Correlation of cyclin D1 and cyclin D3 overexpression with the loss of PTEN expression in endometrial carcinoma
pp. 1668-1672(5)
Authors: WU,; SLOMOVITZ,; SOLIMAN,; SCHMELER,; CELESTINO,; MILAM,; LU,

Overexpression of cyclooxygenase-2 correlates with tumor angiogenesis in endometrial carcinoma
pp. 1673-1678(6)
Authors: LI,; XU,; ZHANG,; JIANG,

Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta
pp. 1679-1684(6)
Authors: PETIGNAT,; LAURINI,; GOFFIN,; BRUCHIM,; BISCHOF,

Integrated ¹⁸F-fluorodeoxyglucose positron emission tomography and computerized tomography in endodermal sinus tumor
pp. 1685-1688(4)
Authors: KLIEGER,; DVIR,; EVEN-SAPIR,; LESSING,; BURSTEIN,; GRISARU,

The management of an early-missed abortion after radical trachelectomy—a case report and a review of the literature
pp. 1688-1690(3)
Authors: LAVIE,; PEER,; SAGI,; BEN ARIE,; AUSLENDER,

No ancillary finding is valid to distinguish a primary ovarian hepatoid carcinoma from metastatic hepatocellular carcinoma
pp. 1691-1694(4)
Authors: KWON,; KIM,; CHO,

Uterine tumor resembling ovarian sex cord tumors in a patient using tamoxifen: report of a case and review of literature
pp. 1694-1697(4)
Authors: OZTEKIN,; SOYLU,; YIGIT,; SARICA,

Abdominal radical trachelectomy: two new surgical techniques for the conservation of uterine arteries
pp. 1698-1704(7)
Authors: WAN,; YAN,; XI,; CAI,

Nerve-sparing class III radical hysterectomy: a modified technique to spare the pelvic autonomic nerves without compromising radicality
pp. 1705-1712(8)
Authors: CHAROENKWAN,; SRISOMBOON,; SUPRASERT,; TANTIPALAKORN,; KIETPEERAKOOL,

Laparoscopic radical trachelectomy or parametrectomy and pelvic and para-aortic lymphadenectomy for cervical or vaginal stump carcinoma: report of six cases
pp. 1713-1716(4)
Authors: LIANG,; XU,; CHEN,; LI,; CHANG,; SHI,